These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1156543)

  • 21. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
    Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-reticulin antibody in jejunal juice in coeliac disease.
    Mawhinney H; Love AH
    Clin Exp Immunol; 1975 Sep; 21(3):394-8. PubMed ID: 1204254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cellular infiltrate of the jejunum in adult coeliac disease and dermatitis herpetiformis following the reintroduction of dietary gluten.
    Lancaster-Smith M; Kumar PJ; Dawson AM
    Gut; 1975 Sep; 16(9):683-8. PubMed ID: 1193423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
    Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
    Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar high frequency of IgA antireticulin and antiendomysial antibodies in dermatitis herpetiformis.
    Reunala T; Hällström O
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1188-9. PubMed ID: 2273136
    [No Abstract]   [Full Text] [Related]  

  • 26. Dermatitis herpetiformis: diagnosis, diet and demography.
    Gawkrodger DJ; Blackwell JN; Gilmour HM; Rifkind EA; Heading RC; Barnetson RS
    Gut; 1984 Feb; 25(2):151-7. PubMed ID: 6693042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-bowel mucosal inflammation in reticulin or gliadin antibody-positive patients without villous atrophy.
    Kaukinen K; Collin P; Holm K; Karvonen AL; Pikkarainen P; Mäki M
    Scand J Gastroenterol; 1998 Sep; 33(9):944-9. PubMed ID: 9759950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study.
    Kaukinen K; Collin P; Holm K; Rantala I; Vuolteenaho N; Reunala T; Mäki M
    Scand J Gastroenterol; 1999 Feb; 34(2):163-9. PubMed ID: 10192194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating reticulin autoantibodies of IgA class in dermatitis herpetiformis.
    Ljunghall K; Scheynius A; Forsum U
    Br J Dermatol; 1979 Feb; 100(2):173-6. PubMed ID: 371658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease.
    Kárpáti S; Meurer M; Stolz W; Bürgin-Wolff A; Braun-Falco O; Krieg T
    Gut; 1992 Feb; 33(2):191-3. PubMed ID: 1541414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgA class reticulin antibodies in relatives of patients with coeliac disease.
    Mallas EG; Williamson N; Cooper BT; Cooke WT
    Gut; 1977 Aug; 18(8):647-50. PubMed ID: 892611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis.
    Garioch JJ; Lewis HM; Sargent SA; Leonard JN; Fry L
    Br J Dermatol; 1994 Oct; 131(4):541-5. PubMed ID: 7947207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective increase of IgA rheumatoid factor in patients with gluten sensitivity.
    Sökjer M; Jónsson T; Bödvarsson S; Jónsdóttir I; Valdimarsson H
    Acta Derm Venereol; 1995 Mar; 75(2):130-2. PubMed ID: 7604641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG-F-actin antibodies in celiac disease and dermatitis herpetiformis.
    Samaşca G; Băican A; Pop T; Pîrvan A; Miu N; Andreica M; Cristea V; Dejica D
    Roum Arch Microbiol Immunol; 2010; 69(4):177-82. PubMed ID: 21462831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential studies of gliadin antibodies in patients with dermatitis herpetiformis.
    Kieffer M; Barnetson RS; Blackwell JN
    Arch Dermatol Res; 1984; 276(2):74-7. PubMed ID: 6721574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet.
    Reunala T; Kosnai I; Karpati S; Kuitunen P; Török E; Savilahti E
    Arch Dis Child; 1984 Jun; 59(6):517-22. PubMed ID: 6742871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reticulin and endomysial antibodies in bullous diseases. Comparison of specificity and sensitivity.
    Kumar V; Hemedinger E; Chorzelski TP; Beutner EH; Valeski JE; Kowalewski C
    Arch Dermatol; 1987 Sep; 123(9):1179-82. PubMed ID: 3307639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum antibodies to wheat germ agglutinin and gluten in patients with dermatitis herpetiformis.
    Sollid LM; Scott H; Kolberg J; Brandtzaeg P
    Arch Dermatol Res; 1986; 278(6):433-6. PubMed ID: 3789802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of coeliac disease in diabetic children and adolescents in Sweden.
    Sigurs N; Johansson C; Elfstrand PO; Viander M; Lanner A
    Acta Paediatr; 1993 Sep; 82(9):748-51. PubMed ID: 8241671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA and IgG reticulin antibodies in coeliac and non-coeliac patients.
    Eade OE; Lloyd RS; Lang C; Wright R
    Gut; 1977 Dec; 18(12):991-3. PubMed ID: 342356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.